BackgroundPsoriasis is recognized as a systemic disease for its accompanying comorbidities, among which psychological disorders present a high incidence rate and affect patients’ life quality. Interleukin (IL)‐17A is the central pathological factor in the pathogenesis and development of psoriasis.ObjectiveTo clarify if psoriasis‐induced systemic IL‐17A increase can mediate the neuronal inflammation and result in depressive‐like symptoms.MethodsPsoriasiform dermatitis model was established by imiquimod (IMQ) application on male BALB/c mice and IL‐17A intervention was performed by lateral ventricular catheterization. Skin structural, histopathological characteristics, and behavioral tests were assessed. Serum IL‐17A levels were detected by Enzyme‐linked immunosorbent assay. mRNA expression of pro‐inflammatory factors IL‐1β, IL‐6, and tumor necrosis factor‐α (TNF‐α) as well as anti‐inflammatory factors IL‐4 and IL‐10 in the hippocampus and cortex were measured by RT‐qPCR. The number of microglia and hippocampal neurons was quantified by immunofluorescent assay.ResultsIMQ treatment resulted in significant skin structural and histopathological characters of psoriasiform dermatitis with elevated serum IL‐17A levels, obvious depressive‐like behaviors, microglia activation with increased IL‐1β, IL‐6, and TNF‐α expression levels in the hippocampus and cortex, and notable inhibition of hippocampal neurogenesis. While, IL‐17A neutralization by intracerebroventricular injection of anti‐IL‐17A antibody can remarkably inhibit microglia activation and decrease the abnormally increased expression levels of IL‐1β, IL‐6, and TNF‐α in the hippocampus and cortex of psoriasiform dermatitis mice, promote hippocampal neurogenesis, thus alleviate the depressive‐like behaviors.ConclusionIn the pathological condition of psoriasis, systemic IL‐17A elevation can trigger microglia activation, provoke pro‐inflammation mediators to release, evoke neuroinflammation, subsequently inhibit hippocampal neurogenesis, and result in depression. IL‐17A, as an important pathogenic factor in psoriasis, contributes to its critical role in mediating systemic inflammation and depression comorbidity.